Intravenous Amantadine for Freezing of Gait Resistant to Dopaminergic Therapy: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Clinical Trial

BACKGROUND: Freezing of gait (FOG) is one of the most disabling symptoms in Parkinsonism. Open-label studies have suggested that intravenous (IV) amantadine is effective against FOG resistant to dopaminergic therapy in Parkinson's disease (PD). We evaluated the efficacy of IV amantadine on FOG...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Young Eun, Yun, Ji Young, Yang, Hui June, Kim, Han-Joon, Gu, Namyi, Yoon, Seo Hyun, Cho, Joo-Youn, Jeon, Beom S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501515/
https://www.ncbi.nlm.nih.gov/pubmed/23185280
http://dx.doi.org/10.1371/journal.pone.0048890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501515/
https://www.ncbi.nlm.nih.gov/pubmed/23185280
http://dx.doi.org/10.1371/journal.pone.0048890

Ejemplares similares